Digoxin
Thông số
20830-75-5Số CAS
244-068-1Số EC
3-[(3S,5R,8R,9S,10S,12R,13S,14S,17R)-3-[(2R,4S,5S,6R)-5-[(2S,4S,5S,6R)-5-[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetTên IUPAC
C41H64O14Công thức hóa học
780.9 g/molKhối lượng phân tử
digoxin; 20830-75-5; Lanoxin; Dilanacin; Rougoxin; Digacin; Digosin; Dynamos; Vanoxin; 12beta-Hydroxydigitoxin; Digoxine; Fargoxin; Lanoxicaps; Mapluxin; Natigoxin; Davoxin; Cardiogoxin; Cordioxil; Digoxina; Digoxinum; Eudigox; Lanacrist; Lanocardin; Toloxin; Stillacor-; Neo-Lanicor; Digoxin Pediatric; SK-Digoxin; Homolle's digitalin; Lanacordin; Acygoxin; Cardioxin; Digoksyna; Digonix; Digossina; Saroxin; Dixina; DTXSID5022934; Lanoxin PG; CHEBI:4551; Chloroformic digitalin; LANOXIN PEDIATRIC; Digoxigenin-tridigitoxosid; NSC-95100; Lenoxin; DTXCID502934; 73K4184T59; Digitalis glycoside; 3-[(3S,5R,8R,9S,10S,12R,13S,14S,17R)-3-[(2R,4S,5S,6R)-5-[(2S,4S,5S,6R)-5-[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one; 3beta,12beta,14-Trihydroxy-5beta,14beta-card-20(22)-enolid-3-tridigitoxosid; (3beta,5beta,12beta)-3-((O-2,6-Dideoxy-beta-D-ribo-hexapyranosyl-(1-4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl)oxy)-12,14-dihydroxycard-20(22)-enolide; 4-[(1S,2S,5S,7R,10R,11S,14R,15S,16R)-5-{[(2R,4S,5S,6R)-5-{[(2S,4S,5S,6R)-5-{[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-11,16-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]-2,5-dihydrofuran-2-one; Card-20(22)-enolide, 3-((O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl)oxy)-12,14-dihydroxy-, (3beta,5beta,12beta)-; Card-20(22)-enolide, 3-((O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1.fwdarw.4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1.fwdarw.4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl)oxy)-12,14-dihydroxy-, (3beta,5beta,12beta)-; Digamex; Digox; NSC95100; Lanoxin-PG; 3-((3S,5R,8R,9S,10S,12R,13S,14S,17R)-3-((2R,4S,5S,6R)-5-((2S,4S,5S,6R)-5-((2S,4S,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl)oxy-4-hydroxy-6-methyloxan-2-yl)oxy-4-hydroxy-6-methyloxan-2-yl)oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta(a)phenanthren-17-yl)-2H-furan-5-one; 4-((1S,2S,5S,7R,10R,11S,14R,15S,16R)-5-(((2R,4S,5S,6R)-5-(((2S,4S,5S,6R)-5-(((2S,4S,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl)oxy)-4-hydroxy-6-methyloxan-2-yl)oxy)-4-hydroxy-6-methyloxan-2-yl)oxy)-11,16-dihydroxy-2,15-dimethyltetracyclo(8.7.0.0^(2,7).0^(11,15))heptadecan-14-yl)-2,5-dihydrofuran-2-one; Nativelle, Digoxine; Boehringer, Digoxina; Lanoxin-125; Nativelle, Hemigoxine; RefChem:5754; C01AA05; 244-068-1; 3beta-(2,6-Dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyloxy)-12beta,14-dihydroxy-5beta,14beta-card-20(22)-enolide; 4-((1S,2S,5S,7R,10R,11S,14R,15S,16R)-5-(((2R,4S,5S,6R)-5-(((2S,4S,5S,6R)-5-(((2S,4S,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl)oxy)-4-hydroxy-6-methyloxan-2-yl)oxy)-4-hydroxy-6-methyloxan-2-yl)oxy)-11,16-dihydroxy-2,15-dimethyltetracyclo(8.7.0.02,7.011,15)heptadecan-14-yl)-2,5-dihydrofuran-2-one; Cardoxin; MLS000069819; MFCD00003674; SMR000059217; Digoxin Nativelle; (3beta,5beta,12beta)-3-{[2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide; NCGC00090797-03; Digoxin, analytical standard; Coragoxine; Lenoxicaps; Neodioxanin; Cardigox; Digomal; Lanikor; Lanorale; Purgoxin; Grexin; Digon; Dokim; Lanoxicaps (TN); [3H]digoxin; 3-[(3S,5R,8R,9S,10S,12R,13S,14S,17R)-3-[(2R,4S,5S,6R)-5-[(2S,4S,5S,6R)-5-[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-4-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-4-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one; SMR000653537; Lanoxin (TN); [3H]-digoxin; Digitek; Dimecip; Lifusin; Digos; Digoxin-Sandoz; Digoxina-Sandoz; Digoxin-Zori; NSC 95100; Digoxin RS; Digoxin CRS; Digoxine Navtivelle; Novodigal [inj.]; Prestwick_170; Digoksyna [Polish]; Digossina [DCIT]; Hemigoxine Nativelle; CAS-20830-75-5; 12b-Hydroxydigitoxin; 12A-Hydroxydigitoxin; 3b0w; DIGOXIN [VANDF]; Digoxinum [INN-Latin]; DIGOXIN [HSDB]; DIGOXIN [IARC]; DIGOXIN [INN]; DIGOXIN [JAN]; DIGOXIN [MI]; Digoxina [INN-Spanish]; DIGOXIN [MART.]; Opera_ID_1134; Prestwick0_000437; Prestwick1_000437; Prestwick2_000437; Prestwick3_000437; Digoxin (JP18/USP); DIGOXIN [USP-RS]; DIGOXIN [WHO-DD]; DIGOXIN [WHO-IP]; Epitope ID:122964; CHEMBL1751; BIDD:PXR0148; SCHEMBL20506; BSPBio_000454; Digoxin, 1mg/ml in Methanol; MLS001055371; MLS001076495; orb104782; DIGOXIN [ORANGE BOOK]; digoxin for peak identification; SPBio_002393; DIGOXIN [EP MONOGRAPH]; BPBio1_000500; GTPL4725; GTPL4726; HSDB 214; DIGOXIN [USP MONOGRAPH]; Digoxin [USP:INN:BAN:JAN]; Digoxin 1.0 mg/ml in Methanol; BDBM46355; cid_2724385; DIGOXINUM [WHO-IP LATIN]; REGID_for_CID_2724385; HMS1569G16; HMS2096G16; HMS2232G20; HMS3713G16; Human Serum - Digoxin, low level; UNII-73K4184T59; Digoxigenin-tridigitoxosid [German]; Digoxin for peak identification CRS; Human Serum - Digoxin, high level; HY-B1049; MSK10026; EINECS 244-068-1; Tox21_111025; Tox21_201678; Tox21_303050; EBC-08615; HB1138; LMST01120023; s4290; AKOS015895113; AKOS024283494; CCG-220437; CS-4571; DB00390; OD01513; BRN 0077011; NCGC00090797-01; NCGC00090797-02; NCGC00090797-04; NCGC00090797-05; NCGC00090797-06; NCGC00090797-07; NCGC00090797-09; NCGC00090797-12; NCGC00090797-15; NCGC00090797-27; NCGC00257022-01; NCGC00259227-01; 4-[(1R,3aS,3bR,5aR,7S,9aS,9bS,11R,11aS)-7-{[(2R,4S,5S,6R)-5-{[(2S,4S,5S,6R)-5-{[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-3a,11-dihydroxy-9a,11a-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-1-yl]-2,5-dihydrofuran-2-one; AS-13281; ST069334; D1828; NS00008620; C06956; D00298; EN300-6492954; 5-18-04-00381 (Beilstein Handbook Reference); Q422222; SR-01000721866; Digoxin, certified reference material, TraceCERT(R); J-013666; SR-01000721866-3; SR-01000721866-4; BRD-K23478508-001-03-7; Digoxin, European Pharmacopoeia (EP) Reference Standard; Z2108699066; 0B9662A7-264E-4ACD-94B2-9E1138C0CA5A; Digoxin, United States Pharmacopeia (USP) Reference Standard; Digoxin, Pharmaceutical Secondary Standard; Certified Reference Material; 3beta,12beta,14-trihydroxy-5beta-card-20(22)-enolide 3-O-(tris-beta-D-digitoxoside); Digoxin for peak identification, European Pharmacopoeia (EP) Reference Standard; -6-methyltetrahydro-2H-pyran-2-yl)oxy)-12,14-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)furan-2(5H)-one; 20(22),5b-Cardenolid-3b,12b,14b-triol 3b-2,6-dideoxy-4-o-[2 ,6-dideoxy-4-o-(2 ,6-dideoxy-b-d-ribohexopyranosyl)-b-d-ribohex opyranoside]; 3-[(3S,5R,10S,12R,13S,14S,17R)-3-[(2R,4S,5S,6R)-5-[(2S,4S,5S,6R)-5-[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one; 3.BETA.-((O-2,6-DIDEOXY-.BETA.-D-RIBO-HEXOPYRANOSYL-(1->4)-O-2,6-DIDEOXY-.BETA.-D-RIBO-HEXOPYRANOSYL-(1->4)-2,6-DIDEOXY-.BETA.-D-RIBO-HEXOPYRANOSYL)OXY)-12.BETA.,14-DIHYDROXY-5.BETA.-CARD-20(22)-ENOLIDE; 3beta-((O-2,6-Dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl)oxy)-12beta,14-dihydroxy-5beta-card-20(22)-enolide; 3beta-{[2,6-Dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl]oxy}-12beta,14-dihydroxy-5beta-card-20(22)-enolide; 4-((1S,2S,5S,11S,15S,7R,10R,14R,16R)-5-{5-[5-((2S,4S,5S,6R)-4,5-dihydroxy-6-me thyl(2H-3,4,5,6-tetrahydropyran-2-yloxy))(4S,5S,2R,6R)-4-hydroxy-6-methyl(2H-3 ,4,5,6-tetrahydropyran-2-yloxy)](4S,5S,2R,; 4-((1S,2S,5S,11S,15S,7R,10R,14R,16R)-5-{5-[5-((2S,4S,5S,6R)-4,5-dihydroxy-6-me thyl(2H-3,4,5,6-tetrahydropyran-2-yloxy))(4S,5S,2R,6R)-4-hydroxy-6-methyl(2H-3 ,4,5,6-tetrahydropyran-2-yloxy)](4S,5S,2R,6R)-4-hydroxy-6-methyl(2H-3,4,5,6-te trahydropyran-2-yl; 4-((3S,5R,8R,9S,10S,12R,13S,14S,17R)-3-(((2R,4S,5S,6R)-5-(((2S,4S,5S,6R)-5-(((2S,4S,5S,6R)-4,5-dihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-hydroxy; 6R)-4-hydroxy-6-methyl(2H-3,4,5,6-te trahydropyran-2-yloxy)}-11,16-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0<2,7>.0 <11,15>]heptadec-14-yl)-5-hydrofuran-2-one; CARD-20(22)-ENOLIDE, 3-((O-2,6-DIDEOXY-.BETA.-D-RIBO-HEXOPYRANOSYL-(1->4)-O-2,6-DIDEOXY-.BETA.-D-RIBO-HEXOPYRANOSYL-(1->4)-2,6-DIDEOXY-.BETA.-D-RIBO-HEXOPYRANOSYL)OXY)-12,14-DIHYDROXY-,(3.BETA.,5.BETA.,12.BETA.)-; Card-20(22)-enolide, 3-((O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl)oxy)-12,14-dihydroxy-, (3beta,5beta,12beta)-; Card-20(22)-enolide, 3-[[O-2,6-dideoxy-.beta.-D-ribo-hexopyranosyl-(1-->4)-O-2,6-dideoxy-.beta.-D-ribo-hexopyranosyl-(1-->4)-2,6-dideoxy-.beta.-D-ribo-hexopyranosyl]oxy]-12,14-dihydroxy-, (3.beta.,5.beta.,12.beta.)-Tên gọi khác
Sản phẩm chứa Digoxin
제일제약디곡신주사액(수출용)카데프엘릭서(디곡신)아주디곡신주사액디고신정(디곡신)ジゴシン注0.25mgジゴシンエリキシル0.05mg/mLジゴキシン錠0.125mg「AFP」/ジゴキシン錠0.25mg「AFP」ジゴキシンKY錠0.25ハーフジゴキシンKY錠0.125ジゴキシン錠0.0625「KYO」ジゴシン散0.1%ジゴシン錠0.25mg
Trang 1/4
Công ty đang bán Digoxin
한림
한림제약(주)Republic of Korea아주
아주약품(주)Republic of Korea에이
에이치케이이노엔(주)Republic of KoreaCT
Công ty TNHH Sản xuất Thương mại Dược phẩm Thành NamViet NamTrang 1/3